Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer

NDAQ:APHA - Post by User

Aphria Inc.

Bullboard Posts

Comment by BuddingInvestoron Jul 16, 2018 9:37pm

122 Views

Post# 28324603

RE:Why Q4 on August 01, will be a home run for investors

GarlicToast wrote: Items that should be on Q4. Not sure about the HIKU shares but i will list it here seeing that the deal is very recent.

APH sold 26.7 million Liberty shares at a price of $1.25 per share = 33 Mill

APH Sold HIKU and will receive $13.7 Million Approximately. Initial investments: Aphria receive 7,194,244 common shares of Hiku at a price of $1.39 per share, Hiku shares sold to Weed @ 1.91

What’s It All Worth?
Aphria will receive 7,194,244 common shares of Hiku at a price of $1.39 per share. Included in the deal for Aphria is a full warrant for each common share it receives, priced at $2.10 per share and exercisable for a two-year period. There is also a forced conversion feature, which prices at $3.05 or roughly 120% of the value of the investment.

8 Positive Quarterly report